Literature DB >> 26579987

Authors' Reply: Is Genotype Testing Really Cost-Effective for Primary Resistance in Brazil?

Paula M Luz1, Beatriz Grinsztejn, Valdilea G Veloso, A David Paltiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26579987      PMCID： PMC4712134          DOI： 10.1097/QAI.0000000000000902

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  2 in total

1.  Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trial.

Authors:  Sarah B Lorenzana; Michael D Hughes; Beatriz Grinsztejn; Ann C Collier; Paula Mendes Luz; Kenneth A Freedberg; Robin Wood; Julie H Levison; Peter N Mugyenyi; Robert Salata; Carole L Wallis; Milton C Weinstein; Robert T Schooley; Rochelle P Walensky
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

2.  Gains in life expectancy from medical interventions--standardizing data on outcomes.

Authors:  J C Wright; M C Weinstein
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.